MMSI

Merit Medical Systems Inc

MMSI, USA

Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally. It operates in two segments, Cardiovascular and Endoscopy. The company provides micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention, including angiography, drainage, delivery systems, and embolotherapy products; spine products, such as vertebral augmentation, radiofrequency ablation, and bone biopsy systems; oncology products; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions. It also offers custom procedural solutions that include critical care products, disinfection protection systems, syringes, manifold kits, and trays and packs; coating services for medical tubes and wires; and sensor components for microelectromechanical systems. In addition, the company provides pulmonary products that consist of laser-cut tracheobronchial stents, over-the-wire and direct visualization delivery systems, and dilation balloons to endoscopically dilate structures; gastroenterology products, such as covered esophageal stents, syringe and gauges, and balloon dilators; and kits and accessories for endoscopy and bronchoscopy procedures, as well as non-pharmacological treatment of gastroesophageal reflux disease. It sells its products to hospitals and alternate site-based physicians, technicians, and nurses through direct sales force, distributors, original equipment manufacturer partners, or custom procedure tray manufacturers. The company was incorporated in 1987 and is headquartered in South Jordan, Utah.

https://www.merit.com

Stock Price

$0.00

0%

decrease compared to yesterday.

Dividend

Frequency:

N/A

Rate:

N/A

Next Payout:

N/A
MMSI
stock
MMSI

Aug Highlights: How liquid is MMSI stock - Quarterly Performance Summary & Technical Confirmation Alerts baoquankhu1.vn

Read more →
MMSI
stock
MMSI

Dow Update: Will MMSI announce a stock split - Weekly Stock Summary & Precise Entry and Exit Recommendations baoquankhu1.vn

Read more →

Showing 2 of 10

Analyst Ratings & Sentiment

(Last Updated 2025-09-30)

Rating:

BUY

Target Price:

$103.6

Analyst Picks

Strong Buy

4

Buy

5

Hold

1

Sell

0

Strong Sell

0

Sentiment:

Bullish

Finn Analysis

(Last Updated 2025-09-30)

Health Score

Price to Earnings Ratio (P/E)

-

Very Low

44.33

Low ≥ 50

High ≤ 10

Price to Book Ratio (P/B)

-

Very High

3.38

Low ≤ 1

High ≥ 3

Return on Equity (ROE)

-

Very Low

1.81 %

Low ≤ 5%

High ≥ 25%

Return on Assets (ROA)

-

Very Low

1.05 %

Low ≤ 2%

High ≥ 10%

Free Cash Flow - Revenue % (FCF)

-

Very High

13.41 %

Low ≤ 5%

High ≥ 15%

Debt to Equity

-

Low

0.72

Low ≥ 1

High ≤ 0.3

Investors

* Institutions hold a combined 99.59% of the total shares of Merit Medical Systems Inc

1.

BlackRock Inc

(14.7169%)

since

2025/06/30

2.

Vanguard Group Inc

(11.5321%)

since

2025/06/30

3.

iShares Core S&P Small-Cap ETF

(5.9345%)

since

2025/08/31

4.

FMR Inc

(4.2912%)

since

2025/06/30

5.

State Street Corp

(3.7461%)

since

2025/06/30

6.

Conestoga Capital Advisors, LLC

(3.7346%)

since

2025/06/30

7.

Vanguard Total Stock Mkt Idx Inv

(3.142%)

since

2025/07/31

8.

Fuller & Thaler Asset Management Inc

(3.0723%)

since

2025/06/30

9.

Amvescap Plc.

(2.6715%)

since

2025/06/30

10.

Macquarie Group Ltd

(2.4592%)

since

2025/06/30

11.

Geode Capital Management, LLC

(2.4273%)

since

2025/06/30

12.

Vanguard Small Cap Index

(2.4221%)

since

2025/07/31

13.

iShares Russell 2000 ETF

(2.3813%)

since

2025/08/31

14.

Maverick Capital Ltd

(2.3293%)

since

2025/06/30

15.

Citadel Advisors Llc

(2.2781%)

since

2025/06/30

16.

Conestoga Small Cap Investors

(2.0357%)

since

2025/07/31

17.

Dimensional Fund Advisors, Inc.

(1.873%)

since

2025/06/30

18.

FullerThaler Behavioral Sm-Cp Eq R6

(1.8491%)

since

2025/06/30

19.

FullerThaler Behavioral Small-Cap Equity

(1.8491%)

since

2025/06/30

20.

Royal Bank of Canada

(1.7955%)

since

2025/06/30

21.

Morgan Stanley - Brokerage Accounts

(1.6935%)

since

2025/06/30

22.

Franklin Resources Inc

(1.4938%)

since

2025/06/30

23.

JPMorgan Chase & Co

(1.4391%)

since

2025/06/30

24.

Vanguard Small Cap Growth Index Inv

(1.363%)

since

2025/07/31

25.

Macquarie Small Cap Core I

(1.3453%)

since

2025/07/31

26.

Loomis, Sayles & Company LP

(1.3403%)

since

2025/06/30

27.

Westwood Holdings Group Inc

(1.2985%)

since

2025/06/30

28.

Goldman Sachs Group Inc

(1.2782%)

since

2025/06/30

29.

William Blair Investment Management, LLC

(1.2489%)

since

2025/06/30

30.

Vanguard Institutional Extnd Mkt Idx Tr

(1.0727%)

since

2025/07/31

31.

Putnam US Small Cap Growth Equity

(1.0351%)

since

2025/06/30

32.

Putnam US Small Cap Growth Managed Acct

(1.0351%)

since

2025/06/30

33.

Putnam Small Cap Growth A

(1.0132%)

since

2025/07/31

34.

Strategic Advisers Fidelity US TtlStk

(1.0012%)

since

2025/07/31

35.

Fidelity Small Cap Index

(0.9894%)

since

2025/06/30

36.

Conestoga Small Cap Growth

(0.9451%)

since

2025/06/30

37.

T. Rowe Price Integrated US SmCapGrEq

(0.8931%)

since

2025/06/30

39.

iShares S&P Small-Cap 600 Growth ETF

(0.8587%)

since

2025/08/31

40.

Invesco Discovery A

(0.8231%)

since

2025/07/31

* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.

Earnings History

EPS ActualEPS EstimateEPS DifferenceSurprise Percent

Upcoming Earnings Release

Date

2025-12-31

EPS Estimate

0.9489

Latest Release

Date

2025-09-30

EPS Actual

0.92

EPS Estimate

0.83

EPS Difference

0.09

Surprise Percent

10.8434%

Investing Fit Scorecard

(Last Updated 2025-09-30)

Deep Value
Potential Value Candidate(4.5)
Defensive
Highly Defensive(8)
Dividend
Weak Dividend Profile(3)
Economic Moat
Wide Moat Company(6.8)
GARP
Fair GARP(3.5)
Growth
Weak Growth Prospect(3)
Momentum
Moderate Momentum(4.5)
Net Net
Not Undervalued (Net-Net)(2.5)
Quality
High Quality(6.5)
Value
Fair Value(4.5)

Income Statement

(Last Updated 2025-09-30)

Revenue

$ 0

Cost Of Revenue

$ 0

Gross Profit

$ 0

Operating Expenses

$ 0

Operating Income

$ 0

Interest Expense

$ 0

Pretax Income

$ 0

Net Income

$ 0

Income Tax Expense

$ 0

EBITDA

$ 0

Total Other Income Expense Net

$ 0

Earnings Per Share

0

Dividends Per Share

0

Shares Outstanding

0

Operating Margin

0%

Trend

Balance Sheet

(Last Updated 2025-09-30)

Cash

$ 0

Short Term Investments

$ 0

Receivables

$ 0

Inventories

$ 0

Total Current Assets

$ 0

Property Plant Equipment

$ 0

Total Assets

$ 0

Payables

$ 0

Short Term Debt

$ 0

Long Term Debt

$ 0

Total Liabilities

$ 0

Equity

$ 0

Trend

Cash Flow

(Last Updated 2025-09-30)

Net Income

$ 0

Depreciation

$ 0

Change In Working Capital

$ 0

Cash From Operations

$ 0

Capital Expenditures

$ 0

Cash From Investing

$ 0

Cash From Financing

$ 0

Net Change In Cash

$ 0

Trend

Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.